Carey Kloss
Carlos Macian
Mr. Ian Lahiffe
Mr. Didier Branellec
Dr. Takahisa Murata
Dr. Takuya Mizuno, Ph.D, DVM
Dr. Yoshifumi Nishikawa
Mr. Zidong Lin
Dr. Kenichi Masuda
Dr. Kenichi Masuda is CEO of Animal Allergy Clinical Laboratories, Inc., established as a RIKEN venture company since 2007. He is also a team leader of Vaccine Innovation Laboratory, RIKEN, actively developing new technologies for allergy testings, therapeutic antibody drugs, and vaccine for emerging zoonosis. One of his recent achievements in small animal medicine is to develop a novel anti-IgE antibody widely cross-reactive among animals and humans, which enables us to measure IgE only associated with allergic diseases and to eliminate IgE producing B cells.
He graduated from Kagoshima University, 1992, and then has engaged in small animal practice as a veterinarian for 3 years. He took a master’s degree major in veterinary medicine from The University of Illinois, 1997, and a Ph.D. degree major in veterinary science from The University of Tokyo, 2003. He used to be a member of International Task Force on Canine Atopic Dermatitis, 2004-2010, and International Committee on Allergic Diseases of Animals, 2010-2019. He is one of leading researchers on allergic diseases in dogs and cats.